Neuroimaging of basal ganglia in neurometabolic diseases in children

9Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Diseases primarily affecting the basal ganglia in children result in characteristic disturbances of movement and muscle tone. Both experimental and clinical evidence indicates that the basal ganglia also play a role in higher mental states. The basal ganglia can be affected by neurometabolic, degenerative diseases or other conditions from which they must be differentiated. Neuroradiological findings in basal ganglia diseases are also known. However, they may be similar in different diseases. Their assessment in children may require repeated MRI examinations depending on the stage of brain development (mainly the level of myelination). A large spectrum of pathological changes in the basal ganglia in many diseases is caused by their vulnerability to metabolic abnormalities and chemical or ischemic trauma. The diagnosis is usually established by correlation of clinical and radiological findings. Neuroimaging of basal ganglia in neurometabolic diseases is helpful in early diagnosis and monitoring of changes for optimal therapy. This review focuses on neuroimaging of basal ganglia and its role in the differential diagnosis of inborn errors of metabolism.

Cite

CITATION STYLE

APA

Paprocka, J., Machnikowska-Sokołowska, M., Gruszczyńska, K., & Emich-Widera, E. (2020, November 1). Neuroimaging of basal ganglia in neurometabolic diseases in children. Brain Sciences. MDPI AG. https://doi.org/10.3390/brainsci10110849

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free